Results 81 to 90 of about 7,400 (105)

[Efficacy of ruxolitinib and prognostic factors in patients with myelofibrosis stratified by age]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Liu XH, Yu Y, Yan FM, Meng Q, Jiang XW, Ji QL, Liu ZY, Zheng YY, Zhou MR, Ma S, Chen CY.   +10 more
europepmc   +1 more source

[Myelodysplastic neoplasms with acute myeloid leukemia-like mutations: clinical features, molecular profiles, and prognosis]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Bao ZF, Liu LL, Li B, Qin TJ, Xu ZF, Qu SQ, Pan LJ, Gao QY, Jiao M, Jia YJ, Li CW, Sun Q, Wang HJ, Xiao ZJ.   +13 more
europepmc   +1 more source

[Clinical effects of antibiotic bone cement and VSD combined with free chimeric anterolateral thigh perforator myocutaneous flaps for sequential treatment of diabetic calcaneal osteomyelitis wounds]. [PDF]

Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
Zhong YH, Cui X, Zhou ST, Guo L, Huang MT, He ZY, Yang HL, Zeng JZ, Liang PF, Zhang PH, Zhou J.   +10 more
europepmc   +1 more source

[A case of toxic shock syndrome secondary to severe bone marrow suppression induced by azathioprine in a patient with autoimmune hepatitis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Ren Y, Kong M, Huang CY, Bian XQ, Liu HX, Mou DL, Chen Y.   +6 more
europepmc   +1 more source

Risk factors for multiple myeloma and its precursor diseases. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Ma W, Zhao L, Zhou W.
europepmc   +1 more source

[miR-488-5p promotes osteogenic and neurogenic differentiation of rat bone marrow mesenchymal stem cells and enhances neuralized bone regeneration]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Zeng L, Cheng K, Liu Z, Li J, Yang J, Jiang T.   +5 more
europepmc   +1 more source

[Research progress on targeted delivery of proteasome inhibitor nanoparticles for the treatment of multiple myeloma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Lin YX, Jing DH, Mi JQ.
europepmc   +1 more source

[Impact of conditioning intensity on transplant outcomes following allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic neoplasms: a multicenter retrospective cohort study]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wang L, Zhang ZL, Zhang RX, Chen HR, Hu ML, Zhao YM, Shi W, Cao Y, Hu XX.   +8 more
europepmc   +1 more source

[Prognostic value of the FS-15 frailty score in patients with myelodysplastic syndromes]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wang X, Qin TJ, Xu ZF, Qu SQ, Li B, Pan LJ, Gao QY, Jiao M, Zhong Y, Jiang BH, Liu LL, Zhao JY, Xie WJ, Xiao ZJ.   +13 more
europepmc   +1 more source

[The role of AKT inhibitors combined with Ruxolitinib in ameliorating myeloproliferative disorders in mice with CALR gene mutations]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhang LW, Zhang QG, Ji MC, Qi KM, Li ZY, Xu KL, Fu CL.   +6 more
europepmc   +1 more source